Overview
Mikko Myllymaki practices in Helsinki, Finland. Myllymaki is rated as an Advanced expert by MediFind in the treatment of Cerebral Hypoxia. Their top areas of expertise are Cerebral Hypoxia, Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), and Adult T-Cell Leukemia.
Their clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Cerebral Hypoxia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cerebral HypoxiaMyllymaki isAdvanced. Learn about Cerebral Hypoxia.
- Chronic Graft Versus Host Disease (cGvHD)
- Experienced
- Adult T-Cell LeukemiaMyllymaki isExperienced. Learn about Adult T-Cell Leukemia.
- AnemiaMyllymaki isExperienced. Learn about Anemia.
- Aplastic AnemiaMyllymaki isExperienced. Learn about Aplastic Anemia.
- Chronic Myelogenous Leukemia (CML)Myllymaki isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- LeukemiaMyllymaki isExperienced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Myllymaki isExperienced. Learn about Myelodysplastic Syndrome (MDS).